Wilk M, Klesper D, Uerlich M, Biwer E, Wimheuer R
Haut- und Poliklinik, Rheinisch-Westfälischen Friedrich-Wilhelms Universität Bonn.
Hautarzt. 1994 May;45(5):324-9. doi: 10.1007/s001050050077.
Chondroid syringoma belongs to the group of so-called mixed tumors, like pleomorphic adenomas of the lacrimal and salivary glands. The histogenesis of this tumour is still disputed, in particular with respect to its stromal component. The distribution of cytokeratins (CKs), CEA, EMA, vimentin, S-100 protein, desmin and actin [alpha-smooth muscle actin (alpha-SMA)] was investigated by immunohistological examination of paraffin sections from a chondroid syringoma of the apocrine type. The neoplastic formations have been classified into tubuloalveolar structures, solid nests/aggregations and stromal cells of varying morphology. The inner-most cells of tubuloalveolar structures were characterized by marked expression of CKs (KL1 and MNF116), CEA and EMA, while in the outer ones there was moderate expression of vimentin, S-100 was expressed to a lesser extent and KL1, weakly but there was marked and consistent expression of MNF116. Whereas the solid nests expressed vimentin, S-100 protein, MNF116 markedly and KL1 weakly, the stromal cells were consistently positive for vimentin, S-100 protein and, focally, CKs and alpha-SMA. Anti-alpha-SMA specifically detects myoepithelial cells. In addition, the partly overlapping immunoreactivity of the intermediate filaments, membrane proteins and proteins in the different structures may indicate a common clonal origin of all neoplastic cells in chondroid syringoma.
软骨样汗腺腺瘤属于所谓的混合瘤,类似于泪腺和唾液腺的多形性腺瘤。该肿瘤的组织发生仍存在争议,尤其是关于其间质成分。通过对一例顶泌汗腺型软骨样汗腺腺瘤石蜡切片进行免疫组织学检查,研究了细胞角蛋白(CKs)、癌胚抗原(CEA)、上皮膜抗原(EMA)、波形蛋白、S-100蛋白、结蛋白和肌动蛋白[α-平滑肌肌动蛋白(α-SMA)]的分布。肿瘤形成可分为管状腺泡结构、实性巢/聚集灶及形态各异的间质细胞。管状腺泡结构最内层细胞的特征是CKs(KL1和MNF116)、CEA和EMA显著表达,而外层细胞波形蛋白呈中度表达,S-100表达程度较低,KL1表达较弱,但MNF116表达显著且一致。实性巢中波形蛋白、S-100蛋白、MNF116显著表达,KL1表达较弱,而间质细胞波形蛋白、S-100蛋白持续阳性,局灶性CKs和α-SMA阳性。抗α-SMA特异性检测肌上皮细胞。此外,不同结构中中间丝、膜蛋白和蛋白质的部分重叠免疫反应性可能表明软骨样汗腺腺瘤中所有肿瘤细胞具有共同的克隆起源。